EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, CTOR: Citius Oncology Inc

10 Nov 25 10:04
LAST:

1.480

CHANGE:
 0.08		OPEN:
1.550		HIGH:
1.570		ASK:
0.000		VOLUME:
39.9K
CHG(%):
5.34		PREV:
1.405		LOW:
1.400		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
10 Nov 251.5501.5701.4001.48039.9K
07 Nov 251.4501.4901.3401.400209.3K
06 Nov 251.5301.5501.3901.440159.4K
05 Nov 251.6501.6501.5001.540127.9K
04 Nov 251.6601.6601.5701.57094.5K
03 Nov 251.7001.7401.6301.67095.7K
31 Oct 251.7601.7801.6801.75086.0K
30 Oct 251.7601.8601.6901.730131.3K
29 Oct 251.7301.9301.7201.750278.2K
28 Oct 251.7401.7501.6801.740396.3K

COMPANY PROFILE

Name:Citius Oncology Inc
About:Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc.
Sector:Healthcare
Address:11 Commerce Drive, Cranford, NJ, United States, 07016
CIK:0001851484
ISIN:US17331Y1091
FIGI:BBG01163HKY3

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:1.480.1%
MA10:1.618.4%
MA20:1.6712.5%
MA50:1.7920.7%
MA100:2.1142.9%
MA200:1.533.6%
STO9:11.32 
STO14:11.32 
RSI14:26.09 
WPR14:-82.86 
MTM14:-0.19
ROC14:-0.12 
ATR:0.13 
Week High:1.7417.6%
Week Low:1.3410.4%
Month High:2.2552.0%
Month Low:1.343.6%
Year High:6.19318.2%
Year Low:0.55168.8%
Volatility:11.03